Venus MedTech (HangZhou)
Latest round
- Series B
Last raised
- Jul 2013
Total raised
- $18M
Investors
- 3
About Venus MedTech (HangZhou)
Founded in 2009 and based in Hangzhou, China, Venus MedTech (HangZhou) Inc. develops an artificial cardiac valve system used in the treatment of aortic stenosis in the form of a catheter-based technology. In December 2019, the company was listed on the Hong Kong Stock Exchange. Its stock code is 02500. As of the end of August 2024, it has more than 800 patents and patent applications, including more than 400 authorized invention patents. The company's main product is the percutaneous interventional heart valve system (TAVR) product. TAVR products include VenusA-Valve, VenusA-Plus, VenusA-Pro and other models.ary valve disease and hypertension. The company’s revenue is generated by providing percutaneous interventional heart valve prosthesis (TAVR) products.
Who invested in Venus MedTech (HangZhou)
3 investors across 3 rounds
See all investors in Venus MedTech (HangZhou)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Venus MedTech (HangZhou)
Who invested in Venus MedTech (HangZhou)?
Venus MedTech (HangZhou) has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Venus MedTech (HangZhou) raised?
Venus MedTech (HangZhou) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Venus MedTech (HangZhou) last raise money?
Venus MedTech (HangZhou)'s most recent round on record is a Series B, in Jul 2013.
What does Venus MedTech (HangZhou) do?
Founded in 2009 and based in Hangzhou, China, Venus MedTech (HangZhou) Inc.
Where is Venus MedTech (HangZhou) headquartered?
Venus MedTech (HangZhou) is headquartered in Hangzhou, China.
Which VCs invest in companies like Venus MedTech (HangZhou)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Venus MedTech (HangZhou)'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Venus MedTech (HangZhou)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.